- Myelopeptide-2 (MP-2)
- Epidermal Growth Factor Receptor Peptide (985-996)
- GTP-Binding Protein Fragment, G alpha
- Laminin (925-933)
- Cadherin Peptide, avian
Adrenomedullin (1-12), humanVasodilator |
Sample solution is provided at 25 µL, 10mM.
Quality Control & MSDS
- View current batch:
- Purity = 98.99%
- COA (Certificate Of Analysis)
- HPLC
- MS (Mass Spectrometry)(Retest)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
Adrenomedullin (1-12), human Dilution Calculator
calculate
Adrenomedullin (1-12), human Molarity Calculator
calculate
Cas No. | N/A | SDF | Download SDF |
Synonyms | H2N-Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-OH | ||
Chemical Name | N/A | ||
Canonical SMILES | N[C@@H](CC1=CC=C(O)C=C1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O | ||
Formula | C64H100N22O19S | M.Wt | 1513.68 |
Solubility | ≥151.3mg/mL in DMSO | Storage | Store at -20°C |
Physical Appearance | A solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
Adrenomedullin (AM) (1-12), human (C64H100N22O19S1), is a peptide with the sequence Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg. It was first discovered to be associated with pheochromocytoma, a tumor arising from adrenal medulla, in 1993. AM was initially identified as a vasodilator, and as such, it has the ability to relax vascular tone. Previous research cited it as the most potent endogenous vasodilatory peptide found in the body. Other effects of AM include the increase of cell tolerance to oxidative stress and hypoxic injury and angiogenesis. AM is seen as a positive influence in diseases such as hypertension, myocardial infarction, chronic obstructive pulmonary disease and other cardiovascular conditions.